Samuel White brings more than 15 years of experience in biopharmaceutical strategy, business development, and corporate leadership. Prior to joining TargED, Samuel served nearly seven years at MorphoSys AG, where he held senior leadership positions, including Chief of Staff to the CEO and Vice President, Head of Corporate Strategy & Commercial Alliance Management, leading key initiatives such as the company’s acquisition by Novartis in 2024.
Earlier in his career, Samuel held leadership roles at Ascension GmbH and AdMare BioInnovations, focusing on early-stage innovation, portfolio development, and strategic collaborations. He holds a Masters of Pharmacy and PhD from Cardiff University.
